Patanjali misleading advertising incident: Supreme Court issues letter to all states/UT licensing authorities not to take any action against advertisements related to Ayurvedic and Ayush products under Section 170 of the Drugs and Cosmetics Rules, 1945 After withdrawing the Centre, the Ministry of Ayush agreed. To withdraw the letter. The Center came after the Supreme Court expressed dissatisfaction with the affidavit defending the letter and said that the letter was issued keeping in view the recommendations of the Ayurveda, Siddha and Unani Drugs Technical Advisory Committee. Agreed to withdraw the letter.
[Rule170oftheDrugsandCosmeticsRules1945prohibitsadvertisingofAyurvedicSiddhaorUnanimedicineswithoutapprovalofthestatelicensingauthorityIntheprevioushearingtheSupremeCourtslammedtheCenterandaskedittoexplainwhyithadissuedsuchaletterTheCenterthenfiledanaffidavitintheSupremeCourtyesterdaydefendingtheletterHoweveritagreedtowithdrawtheletteraftertheSupremeCourttodayslammedtheCentre’sresponse[1945年の医薬品および化粧品規則の規則170では、州の認可当局の承認なしにアーユルヴェーダ、シッダ、またはユナニ薬の広告を禁止しています。前回の公聴会で最高裁判所はセンターを厳しく非難し、なぜこのような書簡を出したのか説明するよう求めた。その後、センターは昨日、この書簡を擁護する宣誓供述書を最高裁判所に提出した。しかし、最高裁判所が本日センターの対応を非難した後、書簡を取り下げることに同意した。
SC asks Ramdev and Patanjali to explain why misleading ads still persist on channel
The Supreme Court today resumed hearing the misleading advertising case filed by the Indian Medical Association (IMA) against Ramdev’s Patanjali Ayurveda and ruled that the misleading advertisements were published on various channels, internet and websites. He expressed displeasure at the continuation.
Also read | Misleading advertising case: SC issues notice to IMA president on Patanjali doctor Acharya Balkrishna’s complaint
The court asked Ramdev’s Patanjali what it was doing to ensure that the agencies running these ads stopped running them. Patanjali has informed the court to come up with a plan to address these misleading advertisements in the next hearing.
In a previous hearing, the Utarkhand government asked the court to suspend the license to manufacture 14 Patanjali products manufactured by Divya Pharmacy and to suspend the company, its managing director Acharya Balkrishna and co-founder Baba Ramdev. He said he has filed a criminal complaint. Drugs and Magical Remedies (Offensive Advertising) Act 1954.
Today, the Supreme Court asked Patanjali why it continues to advertise these products and what steps it is taking to ensure they stop.
SC orders broadcasters and advertisers to submit self-reports
In a significant development, after hearing the case, the Supreme Court will require broadcasters to submit self-declaration statements before running ads, ensuring that ads run on their platforms comply with cable network rules, advertising codes, etc. I ordered him to certify that he was doing so.
“As a remedial measure, we consider it appropriate to direct that a self-declaration be obtained before allowing advertisements… has to obtain a self-declaration,” the bench said.
The Supreme Court further emphasized that: celebrities, social media influencers You are equally responsible for misleading advertising if you endorse deceptive products or services.
“We believe advertisers, advertising agencies and endorsers are equally responsible for publishing false and misleading advertisements.”
